| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
2004-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee67bbae631e9743b3c7bcdad99d9c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa4301758ce57ad023ad217cbaa8e4c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79d4396317426865bc79e36362ea22b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8244cc28db5dc583df887ef167a34f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7088a1cc69de50826ef020758bc05db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ff7196258db5a9608323f3eaad60503 |
| publicationDate |
2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7482340-B2 |
| titleOfInvention |
Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| abstract |
Therapeutically active compounds of formula (I) or (II): n nwherein the variables in formulas (I) and (II) are defined in the description, and pharmaceutically acceptable salts and esters thereof. The compounds are potent inhibitors of Na + /Ca 2+ exchange mechanism. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10766860-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11459309-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150732-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11358936-B2 |
| priorityDate |
2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |